II
Illudent, Inc.
SEC filingPharmaceuticals · San Diego, CA
Amount raised$3.2Msold at filing
Total offering$4M$825K still open
Investors in the raise11count reported to the SEC
FiledAug 15, 2025first sale Aug 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael J. KelnerExecutive Officer, Director
Joe J. GattoExecutive Officer, Director
Clint J. KorverDirector
Executive officers, directors and promoters as listed on the Form D.